Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRE-AF: Anticoagulation for Stroke Prevention in Perioperative Atrial Fibrillation After Noncardiac Surgery
2019-001336-62Phase 4Active
- Sponsor
- Hamilton Health Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of apixaban, edoxaban, rivaroxaban and dabigatran in Atrial fibrillation (AFib), stroke, systemic embolism and 1 more (2 arms), sponsored by Hamilton Health Sciences. Started Nov 2019; status: active.
02
Drugs
apixabanedoxabanrivaroxabandabigatran
03
Conditions
Atrial fibrillation (AFib)strokesystemic embolismvenous thromboembolism (VTE)
Beyond the preview
Go deeper on 2019-001336-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001336-62.